Reviewing "apinaca", an emergent synthetic cannabinoid receptor agonist

被引：1
|
作者：
Dinamarca, F. [1 ]
Grifell, M. [2 ]
Galindo, L. [1 ]
Campillo, M. [2 ]
Torrens, M. [1 ]
Perez, V. [2 ]
Farre, M. [2 ]
机构：
[1] Hosp del Mar, Psiquiatria, Barcelona, Spain
[2] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30885-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.6.d.024
引用
收藏
页码：S626 / S626
页数：1
相关论文
共 50 条
  • [1] Clinical toxicity of synthetic cannabinoid receptor agonist use
    Manini, Alex F.
    Hoffman, Robert S.
    Stimmel, Barry
    Vlahov, David
    [J]. CLINICAL TOXICOLOGY, 2015, 53 (04) : 356 - 357
  • [2] Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018
    Finlay, David B.
    Thuy Nguyen
    Gamage, Thomas F.
    Chen, Shuli
    Barrus, Daniel G.
    Patel, Purvi R.
    Thomas, Brian F.
    Wiley, Jenny L.
    Zhang, Yanan
    Glass, Michelle
    [J]. PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (01):
  • [3] A synthetic cannabinoid receptor agonist (AB-FUBINACA)-associated fatality
    Fernandez, Denise
    Hammer, Jennifer
    De Olano, Jonathan
    Nelson, Lewis S.
    Hoffman, Robert S.
    Su, Mark K.
    [J]. CLINICAL TOXICOLOGY, 2016, 54 (04) : 408 - 408
  • [4] Poisoning due to MDMB-CHMICA, a synthetic cannabinoid receptor agonist
    Meyyappan, Chitra
    Ford, Loretta
    Vale, Allister
    [J]. CLINICAL TOXICOLOGY, 2017, 55 (02) : 151 - 152
  • [5] Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
    Zagzoog, Ayat
    Brandt, Asher L.
    Black, Tallan
    Kim, Eunhyun D.
    Burkart, Riley
    Patel, Mikin
    Jin, Zhiyun
    Nikolaeva, Maria
    Laprairie, Robert B.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
    Ayat Zagzoog
    Asher L. Brandt
    Tallan Black
    Eunhyun D. Kim
    Riley Burkart
    Mikin Patel
    Zhiyun Jin
    Maria Nikolaeva
    Robert B. Laprairie
    [J]. Scientific Reports, 11
  • [7] Synthetic Cannabinoid Receptor Agonist-Associated Psychotic Disorder: A Case Report
    Sonmez, Ipek
    Kosger, Ferdi
    [J]. TURK PSIKIYATRI DERGISI, 2016, 27 (01) : 63 - 66
  • [8] Driving Under the Influence of Synthetic Cannabinoid Receptor Agonist XLR-11
    Lemos, Nikolas P.
    [J]. JOURNAL OF FORENSIC SCIENCES, 2014, 59 (06) : 1679 - 1683
  • [9] Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds
    Wouters, Elise
    Walraed, Jolien
    Robertson, Michael Joseph
    Meyrath, Max
    Szpakowska, Martyna
    Chevigne, Andy
    Skiniotis, Georgios
    Stove, Christophe
    [J]. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (02) : 285 - 295
  • [10] Synthetic cannabinoid receptor agonist (SCRA) toxicity reported to the Victorian Poisons Information Centre
    Wong, Anselm Y.
    Macleod, Dawson
    Greene, Shaun L.
    [J]. CLINICAL TOXICOLOGY, 2016, 54 (04) : 396 - 397
12345